133 related articles for article (PubMed ID: 35253621)
21.
Nagamalla L; Kumar JVS
J Biomol Struct Dyn; 2021 Apr; 39(6):2056-2070. PubMed ID: 32178589
[TBL] [Abstract][Full Text] [Related]
22. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
23. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
[TBL] [Abstract][Full Text] [Related]
24.
Kumar R; Kumar R; Tanwar P
J Biomol Struct Dyn; 2022 Oct; 40(16):7394-7407. PubMed ID: 33715592
[TBL] [Abstract][Full Text] [Related]
25. [Tbx3 upregulation may be one of the malignant biomarkers of breast cancer].
Chen ZH; Lv GM; Ji TH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):765-7. PubMed ID: 19403417
[TBL] [Abstract][Full Text] [Related]
26. Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.
Perkhofer L; Walter K; Costa IG; Carrasco MC; Eiseler T; Hafner S; Genze F; Zenke M; Bergmann W; Illing A; Hohwieler M; Köhntop R; Lin Q; Holzmann KH; Seufferlein T; Wagner M; Liebau S; Hermann PC; Kleger A; Müller M
Stem Cell Res; 2016 Sep; 17(2):367-378. PubMed ID: 27632063
[TBL] [Abstract][Full Text] [Related]
27. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract][Full Text] [Related]
28. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
[TBL] [Abstract][Full Text] [Related]
29. The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer.
Douglas NC; Papaioannou VE
J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):143-7. PubMed ID: 23624936
[TBL] [Abstract][Full Text] [Related]
30. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract][Full Text] [Related]
31. Identification of common genes in obesity and cancer through network interaction and targeting those genes by virtual screening approach.
Modanwal S; Mishra N
J Biomol Struct Dyn; 2023 Feb; 41(3):1109-1127. PubMed ID: 34961392
[TBL] [Abstract][Full Text] [Related]
32. Human breast progenitor cell numbers are regulated by WNT and TBX3.
Arendt LM; St Laurent J; Wronski A; Caballero S; Lyle SR; Naber SP; Kuperwasser C
PLoS One; 2014; 9(10):e111442. PubMed ID: 25350852
[TBL] [Abstract][Full Text] [Related]
33. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
36.
Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
[TBL] [Abstract][Full Text] [Related]
37. Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma.
Nagel S; Meyer C
PLoS One; 2021; 16(11):e0259674. PubMed ID: 34807923
[TBL] [Abstract][Full Text] [Related]
38.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
39.
Parvizpour S; Elengoe A; Alizadeh E; Razmara J; Shamsir MS
J Biomol Struct Dyn; 2023 Nov; 41(19):10037-10050. PubMed ID: 36451602
[TBL] [Abstract][Full Text] [Related]
40. Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors
Alakhdar AA; Saleh AH; Arafa RK
J Biomol Struct Dyn; 2022 Jan; 40(1):276-289. PubMed ID: 32851933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
